The Effect of miR-210 Up-regulation on Proliferation and Survival of Mouse Bone Marrow Derived Mesenchymal Stem Cell
-
Neda Minayi
,
Shaban Alizadeh
,
Hossein Dargahi
,
Masoud Soleimani
,
Zahra Kashani Khatib
,
Behnoosh Tayebi
,
Mozhde Mohammadian
,
Sadegh Alijani
,
Farshid Karami
Abstract
Background: Bone marrow derived mesenchymal stem cells (MSCs) are a population of multipotent progenitors which have the capacity of proliferation and differentiation into mesenchymal lineage cells. Hypoxia could promote the proliferation of MSCs. Micro-RNAs are endogenous RNAs that can play an important role in some processes such as proliferation and differentiation. MiR-210 could help for better proliferation of MSCs since this miRNA could activate HIF pathway. In current study we investigated if MSCs can preserve their differentiation and proliferation ability under normoxic conditions by upregulation of miR-210.
Materials and Methods: MSCs isolated from C57 BL/6 mice by flushing it's femurs into the cell culture media. After 72 hours, MSCs which are plastic adherent cells were attached to the flask and non-adherent cells were removed. Subsequently, MSCs induced to differentiate into osteocytes and adipocytes with specific differentiation media in order to confirm their identity and multipotency. Then miR-210 was inserted in Lentiviruse vectors and affected MSCs. In each passage, the number and viability of cells were evaluated.
Results: Comparison between miR-210 infected MSCs with control cells showed that miR-210 has ability to increase proliferation of MSCs significantly.
Conclusion: We showed that miR-210 has ability to induce proliferation of MSCs without any negative effect on their differentiation abilities. Further studies are needed for evaluation of probable effects of miR-210 mechanisms on MSCs proliferation.
Arai F, Ohneda O, Miyamoto T, Zhang XQ, Suda T. Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med. 2002;195(12):1549-63.
Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthr Cartilage. 2005;13:845-53.
Campagnoli C, Roberts IA, Kumar S. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood Rev. 2001;98:2396-402.
Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9(5):641-50.
M O, AJ F. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp. 1988;136:42-60.
MK M, MA T, JD M. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol Rev. 1998;176:57-66.
Moriscot C, de Fraipont F, Richard MJ, Marchand M, Savatier P, Bosco D, et al. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells. 2005;23(4):594-603.
Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4(5):267-74.
Ma T, Grayson WL, Zhao F, Bunnell B. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Bioph Res Commun. 2007;358:948-53.
Wang Y, Yang J, Li H, Wang X, Zhu L, Fan M, et al. Hypoxia Promotes Dopaminergic Differentiation of Mesenchymal Stem Cells and Shows Benefits for Transplantation in a Rat Model of Parkinson’s Disease. PLoS One. 2013;8(1):1-12.
Fu WL, Jia ZQ, Wang WP, Zhang JY, Fu X, Duan XN, et al. Proliferation and apoptosis property of mesenchymal stem cells derived from peripheral blood under the culture conditions of hypoxia and serum deprivation. Chin Med J 2011;124(23):3959-67.
Lee EY, Xia Y, Kim WS, Kim MH, Kim TH, Kim KJ, et al. Hypoxia‐enhanced wound‐healing function of adipose‐derived stem cells: Increase in stem cell proliferation and up‐regulation of VEGF and bFGF. Wound Repair and Regeneration. 2009;17(4):540-7.
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. cell. 2004;116(2):281-97.
Rana TM. Illuminating the silence: understanding the structure and function of small RNAs. Nature reviews Molecular cell biology. 2007;8(1):23-36.
Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Molecular cell. 2009;35(6):856-67.
Bartel DP. MicroRNAs: target recognition and regulatory functions. cell. 2009;136(2):215-33.
AkbarPourfathollah A, Abroun S. Mir-155 Downregulation by miRCURY LNA™ microRNA Inhibitor Can Increase alpha Chain Hemoglobins Expression in Erythroleukemic K562 Cell Line. International Journal of Hematology-Oncology and Stem Cell Research. 2010;4(2).
Kouhkan F, Alizadeh S, Kaviani S, Soleimani M, Pourfathollah AA, Amirizadeh N, et al. miR-155 down regulation by LNA inhibitor can reduce cell growth and proliferation in PC12 cell line. Avicenna Journal of Medical Biotechnology. 2011;3(2):61.
Calin GA, Liu C-G, Sevignani C, Ferracin M, Felli N, Dumitru CD, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(32):11755-60.
Farh KK-H, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science. 2005;310(5755):1817-21.
Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS. Post-transcriptional gene silencing by siRNAs and miRNAs. Current opinion in structural biology. 2005;15(3):331-41.
Karp X, Ambros V. Encountering microRNAs in cell fate signaling. Science. 2005;310(5752):1288-9.
Miska EA. How microRNAs control cell division, differentiation and death. Current opinion in genetics & development. 2005;15(5):563-8.
Seila AC, Sharp PA. Small RNAs tell big stories in Whistler. Nature cell biology. 2008;10(6):630-3.
Guarnieri DJ, DiLeone RJ. MicroRNAs: a new class of gene regulators. Annals of medicine. 2008;40(3):197-208.
Leung AK, Sharp PA. microRNAs: a safeguard against turmoil? cell. 2007;130(4):581-5.
Croce CM, Calin GA. miRNAs, cancer, and stem cell division. cell. 2005;122(1):6-7.
He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435(7043):828-33.
Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer research. 2005;65(16):7065-70.
Liu C-G, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(26):9740-4.
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834-8.
Mathew LK, Simon MC. mir-210: a sensor for hypoxic stress during tumorigenesis. Molecular cell. 2009;35(6):737-8.
Ivan M, Harris AL, Martelli F, Kulshreshtha R. Hypoxia response and microRNAs: no longer two separate worlds. Journal of cellular and molecular medicine. 2008;12(5a):1426-31.
Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, Hasegawa K, et al. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer biology & therapy. 2008;7(2):255-64.
Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. Journal of Biological Chemistry. 2008;283(23):15878-83.
Pulkkinen K, Malm T, Turunen M, Koistinaho J, Ylä-Herttuala S. Hypoxia induces microRNA miR-210 in vitro and in vivo: Ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS letters. 2008;582(16):2397-401.
Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, et al. A microRNA signature of hypoxia. MOLECULAR AND CELLULAR BIOLOGY. 2007;27(5):1859-67.
Crosby ME, Kulshreshtha R, Ivan M, Glazer PM. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer research. 2009;69(3):1221-9.
Adams J, Difazio L, Rolandelli R, Lujan J, Hasko G, Csoka B, et al. HIF-1: a key mediator in hypoxia (Review). Acta Physiologica Hungarica. 2009;96(1):19-28.
Corn PG. Role of the ubiquitin proteasome system in renal cell carcinoma. BMC biochemistry. 2007;8(Suppl 1):S4.
Weidemann A, Johnson R. Biology of HIF-1α. Cell Death & Differentiation. 2008;15(4):621-7.
Peterson KM, Aly A, Lerman A, Lerman LO, Rodriguez-Porcel M. Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress. Life sciences. 2011;88(1):65-73.
Chin BY, Jiang G, Wegiel B, Wang HJ, MacDonald T, Zhang XC, et al. Hypoxia-inducible factor 1α stabilization by carbon monoxide results in cytoprotective preconditioning. Proceedings of the National Academy of Sciences. 2007;104(12):5109-14.
Kim HW, Haider HK, Jiang S, Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. Journal of Biological Chemistry. 2009;284(48):33161-8.
Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovascular research. 2008;77(1):134-42.
Wang J-a, Chen T-l, Jiang J, Shi H, Gui C, Luo R-h, et al. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacologica Sinica. 2008;29(1):74-82.
Jiang B-H, Semenza GL, Bauer C, Marti HH. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. American Journal of Physiology-Cell Physiology. 1996;271(4):C1172-C80.
Semenza GL, Jiang B-H, Leung SW, Passantino R, Concordet J-P, Maire P, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. Journal of Biological Chemistry. 1996;271(51):32529-37.
Huang X, Le Q-T, Giaccia AJ. MiR-210–micromanager of the hypoxia pathway. Trends in molecular medicine. 2010;16(5):230-7.
Nie Y, Han B-M, Liu X-B, Yang J-J, Wang F, Cong X-F, et al. Identification of MicroRNAs involved in hypoxia-and serum deprivation-induced apoptosis in mesenchymal stem cells. International journal of biological sciences. 2011;7(6):762.
W C, Ch L, J P, M P, L M, C Y, et al. Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1. J Vet Sci. 2013;14(1): 69-76.
Chan SY, Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle. 2010;9(6):1072-83.
Zhang Z, Sun H, Dai H, Walsh R, Imakura M, Schelter J, et al. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle. 2009;8(17):2756-68.
Hurlin P, Queva C, Eisenman R. Mnt: a novel Max-interacting protein and Myc antagonist. C-Myc in B-Cell Neoplasia: Springer; 1997. p. 115-21.
Hurlin PJ, Queva C, Eisenman RN. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes & development. 1997;11(1):44-58.
L H. Carrot and stick: HIF-a engages c-Myc in hypoxic adaptation. Cell Death and Differentiation. 2008;15: 672-7.
J G, J B, Ch H, J D, M S. HIF-2a Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity. Cancer Cell 2007;11:335-47.
J G, C T, M S. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell August 2007;12(2):108-13.
H R, Y C, Q Z, J L, C Z, L L, et al. Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. Biochemical and Biophysical Research Communications 2006;347:12-21.
Fehrer C, Brunauer R, Laschober G, Unterluggauer H, Reitinger S, Kloss F, et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging cell. 2007;6(6):745-57.
F DS, P A, J B, M A, C DS, J C. Ex Vivo Expansion of Human Mesenchymal Stem Cells: A More Effective Cell Proliferation Kinetics and Metabolism Under Hypoxia. J Cell Physiol. 2010; 223: 27-35.
| Files | ||
| Issue | Vol 8, No 1 (2014) | |
| Section | Articles | |
| Keywords | ||
| HIF-1α Mesenchymal stem cells MiR-210 | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
